EMBER 3
EMBER-3: Imlunestrant ± Abemaciclib vs SoC ET in Patients With ER+/HER2- ABC After Progression on Prior ET

Released: December 13, 2024

Expiration: June 12, 2025

Activity

Progress
1
Course Completed